Table 4.
Summary of effective dose, E, predicted lifetime SMN incidence, I, and predicted lifetime SMN mortality, M, from neutrons. IT and MT are predicted lifetime SMN incidence and predicted lifetime SMN mortality, respectively, due to neutrons for specific cancer sites that correspond to organs and tissues, T.
Outcome | Girl | Boy |
---|---|---|
E (mSv) | 428 | 418 |
I (%) | 14.8 | 8.5 |
M (%) | 5.3 | 3.4 |
Cancer sites with IT > 0.8% | Breast, lung, skin, thyroid | Skin, lung, colon |
Cancer sites with MT > 0.4% | Lung, breast | Lung, colon |